Document is current
Any future updates will be listed below
-
Authors
Charoenngam, Nipith https://orcid.org/0000-0002-6501-6180
Ilori, Titilayo O.
Holick, Michael F.
Hochberg, Natasha S.
Apovian, Caroline M.
-
Funding
Funding for this research was provided by:
National Institutes of Health (2 T32 DK 7201-42)
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK11954201)
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK046200)
School of Medicine, Boston University
Warren Alpert Foundation
- License Information
-
More Information
Article History
Received: 1 February 2021
Accepted: 11 May 2021
First Online: 7 June 2021
Declarations
:
: Michael F. Holick is a former consultant for Quest Diagnostics Inc., a consultant for Biogena Inc. and Ontometrics Inc., and on the speaker’s Bureau for Abbott Inc. Caroline M. Apovian reports receiving personal fees from Nutrisystem, Zafgen, Sanofi-Aventis, Orexigen, EnteroMedics, GI Dynamics, Scientific Intake, Gelesis, Novo Nordisk, SetPoint Health, Xeno Biosciences, Rhythm Pharmaceuticals, Eisai, and Takeda outside of the funded work; reports receiving grant funding from Aspire Bariatrics, GI Dynamics, Orexigen, Takeda, the Vela Foundation, Gelesis, Energesis, Coherence Lab, and Novo Nordisk outside of the funded work; and reports past equity interest in ScienceSmart, LLC.
Free to read: This content has been made available to all.
